CanSino Biologics' market value is the price at which a share of CanSino Biologics trades on a public exchange. It measures the collective expectations of CanSino Biologics investors about its performance. CanSino Biologics is trading at 4.90 as of the 26th of July 2025. This is a 6.06 percent increase since the beginning of the trading day. The stock's lowest day price was 4.9. With this module, you can estimate the performance of a buy and hold strategy of CanSino Biologics and determine expected loss or profit from investing in CanSino Biologics over a given investment horizon. Check out CanSino Biologics Correlation, CanSino Biologics Volatility and CanSino Biologics Alpha and Beta module to complement your research on CanSino Biologics.
Please note, there is a significant difference between CanSino Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CanSino Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CanSino Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CanSino Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CanSino Biologics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CanSino Biologics.
0.00
06/26/2025
No Change 0.00
0.0
In 31 days
07/26/2025
0.00
If you would invest 0.00 in CanSino Biologics on June 26, 2025 and sell it all today you would earn a total of 0.00 from holding CanSino Biologics or generate 0.0% return on investment in CanSino Biologics over 30 days. CanSino Biologics is related to or competes with Canopy Growth, Tilray, SINOPHARM GROUP, Shanghai Fosun, Sinopharm Group, and Lonza Group. CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the Peoples Republic of China More
CanSino Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CanSino Biologics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CanSino Biologics upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for CanSino Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CanSino Biologics' standard deviation. In reality, there are many statistical measures that can use CanSino Biologics historical prices to predict the future CanSino Biologics' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as CanSino Biologics. Your research has to be compared to or analyzed against CanSino Biologics' peers to derive any actionable benefits. When done correctly, CanSino Biologics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in CanSino Biologics.
CanSino Biologics Backtested Returns
CanSino Biologics appears to be unstable, given 3 months investment horizon. CanSino Biologics secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14 % return per unit of risk over the last 3 months. By analyzing CanSino Biologics' technical indicators, you can evaluate if the expected return of 0.81% is justified by implied risk. Please makes use of CanSino Biologics' Mean Deviation of 1.48, risk adjusted performance of 0.1163, and Standard Deviation of 5.5 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, CanSino Biologics holds a performance score of 11. The firm shows a Beta (market volatility) of -0.57, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning CanSino Biologics are expected to decrease at a much lower rate. During the bear market, CanSino Biologics is likely to outperform the market. Please check CanSino Biologics' total risk alpha, as well as the relationship between the daily balance of power and day typical price , to make a quick decision on whether CanSino Biologics' price patterns will revert.
Auto-correlation
0.00
No correlation between past and present
CanSino Biologics has no correlation between past and present. Overlapping area represents the amount of predictability between CanSino Biologics time series from 26th of June 2025 to 11th of July 2025 and 11th of July 2025 to 26th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CanSino Biologics price movement. The serial correlation of 0.0 indicates that just 0.0% of current CanSino Biologics price fluctuation can be explain by its past prices.
Correlation Coefficient
0.0
Spearman Rank Test
1.0
Residual Average
0.0
Price Variance
0.62
CanSino Biologics lagged returns against current returns
Autocorrelation, which is CanSino Biologics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CanSino Biologics' pink sheet expected returns. We can calculate the autocorrelation of CanSino Biologics returns to help us make a trade decision. For example, suppose you find that CanSino Biologics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
CanSino Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CanSino Biologics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CanSino Biologics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CanSino Biologics pink sheet over time.
Current vs Lagged Prices
Timeline
CanSino Biologics Lagged Returns
When evaluating CanSino Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CanSino Biologics pink sheet have on its future price. CanSino Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CanSino Biologics autocorrelation shows the relationship between CanSino Biologics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in CanSino Biologics.
Other Information on Investing in CanSino Pink Sheet
CanSino Biologics financial ratios help investors to determine whether CanSino Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CanSino with respect to the benefits of owning CanSino Biologics security.